About MRA » Letter from the President
It has been an eventful month for MRA! The first deadlines are fast-approaching for our eighth annual Request for Proposals, we hosted our first-ever Patient Forum and we have begun planning for our next Scientific Retreat, scheduled for February 2015 in Washington, DC. These activities build upon our work with the American Association for Cancer Research (AACR), which hosted the special Advances in Melanoma Conference late last month in Philadelphia, providing MRA leadership and many MRA-supported investigators a platform to discuss latest developments in the field.
Just this past weekend, MRA and the Global Resource for Advancing Cancer Education (GRACE) were in Chicago to co-host a unique, cross-tumor type immunotherapy patient forum, presenting an all-star line-up of experts in oncology and immunotherapy, not just for melanoma patients but also lung and kidney cancers. For those who could not attend the event in person, we will be sharing footage of the forum online—so stay tuned!
As we look forward to the fourth quarter of 2014, we remain focused on efforts to find and fund the most impactful melanoma research. There are promising therapies in late-stage development that we hope will soon become broadly available for patients even as clinical trials and expanded access programs remain important options today. As always, we appreciate the hard work of so many allies with whom we are collaborating toward achieving our mission of defeating melanoma.
Wendy K.D. Selig
President and CEO
MELANOMA RESEARCH ALLIANCE FOUNDATION (Melanoma Research Alliance; MRA) is a GuideStar Exchange Gold Participant Want to learn more about the GuideStar Exchange?
Click here »